Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
J Immunol ; 202(1): 300-308, 2019 01 01.
Article in English | MEDLINE | ID: mdl-30510065

ABSTRACT

Advances in imaging have led to the development of powerful multispectral, quantitative imaging techniques, like histo-cytometry. The utility of this approach is limited, however, by the need for time consuming manual image analysis. We therefore developed the software Chrysalis and a group of Imaris Xtensions to automate this process. The resulting automation allowed for high-throughput histo-cytometry analysis of three-dimensional confocal microscopy and two-photon time-lapse images of T cell-dendritic cell interactions in mouse spleens. It was also applied to epi-fluorescence images to quantify T cell localization within splenic tissue by using a "signal absorption" strategy that avoids computationally intensive distance measurements. In summary, this image processing and analysis software makes histo-cytometry more useful for immunology applications by automating image analysis.


Subject(s)
Dendritic Cells/pathology , Image Processing, Computer-Assisted/methods , Immunological Synapses/pathology , Software , T-Lymphocytes/pathology , Animals , Automation, Laboratory , Cells, Cultured , Female , High-Throughput Screening Assays , Mice , Mice, Inbred C57BL , Microscopy, Confocal , Spleen/pathology , Time-Lapse Imaging
2.
Hepatology ; 53(5): 1436-45, 2011 May.
Article in English | MEDLINE | ID: mdl-21294144

ABSTRACT

UNLABELLED: Liver transplantation (LT) is a unique model to study hepatitis C virus (HCV) entry into hepatocytes. Recent in vitro studies suggest significant changes in the expression of the HCV receptors claudin-1 and occludin after HCV infection. Our aims were: (1) to characterize claudin-1 and occludin expression in grafts from LT recipients and (2) to explore their potential influence on early HCV kinetics and their changes after HCV infection. We included 42 HCV-infected LT recipients and 19 uninfected controls. Claudin-1 and occludin were detected in paraffin-embedded liver biopsies obtained during reperfusion and 3 and 12 months after LT. HCV receptors were characterized by confocal immunofluorescence microscopy; quantification and colocalization studies were performed with dedicated software. Claudin-1 and occludin expression were restricted to the apical pole of hepatocytes. There was a significant correlation between the amount of scavenger receptor B1 at the time of reperfusion and the HCV-RNA decay during the first 24 hours following LT (r = 0.55, P = 0.007). Similarly, there was a significant correlation between the levels of claudin and occludin and the slope of HCV-RNA increase during the first week after LT (r = 0.63, P = 0.005). Occludin and claudin-1 levels increased significantly 12 months after LT (P = 0.03 and P = 0.007, respectively). The expression pattern of both proteins, however, remained unchanged, colocalizing strongly (60%-94%) at the apical membrane of hepatocytes. CONCLUSIONS: HCV receptor levels at the time of LT seem to modulate early HCV kinetics. Hepatitis C recurrence after LT was associated with increased levels of claudin-1 and occludin in the hepatocyte cell membrane, although it did not alter their localization within the tight junctions.


Subject(s)
Hepacivirus/physiology , Hepatitis C/virology , Liver Transplantation , Membrane Proteins/biosynthesis , Receptors, Virus/biosynthesis , Adult , Aged , Claudin-1 , Female , Humans , Male , Middle Aged , Occludin , Retrospective Studies
3.
Endocr Relat Cancer ; 17(2): 513-24, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20304979

ABSTRACT

The hyperparathyroidism-jaw tumor syndrome (HPT-JT) is a familial cancer syndrome that can result from germline inactivation of HRPT2/CDC73, a putative tumor suppressor gene that encodes parafibromin, a component of the transcriptional regulatory PAF1 complex with homology to the yeast protein Cdc73p. The vast majority of HRPT2/CDC73 germline mutations identified have been truncation or frameshift mutations, and loss of function due to missense mutation is rare. We report here a kindred with HPT-JT due to a germline L95P missense mutation in parafibromin. The mutant parafibromin was studied in vitro to understand the basis of its presumed loss-of-function. When transfected in cultured cells, the L95P mutant was expressed to a lower level than wild-type (wt) parafibromin, a difference that was not overcome by inhibition of the proteasomal degradation pathway. The L95P mutant parafibromin retained the ability to assemble with endogenous PAF1 complex components as evidenced by co-immunoprecipitation. Analysis of subcellular localization showed that the L95P mutant was markedly deficient in nucleolar localization compared to the wt, an impairment likely resulting from disruption of a putative nucleolar localization signal immediately upstream of the L95P mutation. Transfection of the L95P parafibromin mutant, but not the wt, enhanced cell cycle progression and increased cell survival in NIH-3T3 and HEK 293 cells, resulting apparently from dominant interference with endogenous parafibromin action. The simultaneous loss of nucleolar localization and acquisition of a growth stimulatory phenotype with the L95P mutation raise the possibility that parafibromin must interact with targets in the nucleolus to fully execute its tumor suppressor functions.


Subject(s)
Carcinoma/genetics , Cell Nucleolus/metabolism , Hyperparathyroidism/genetics , Jaw Neoplasms/genetics , Mutation, Missense , Tumor Suppressor Proteins/genetics , Tumor Suppressor Proteins/metabolism , Amino Acid Sequence , Amino Acid Substitution/genetics , Amino Acid Substitution/physiology , Animals , Carcinoma/complications , Carcinoma/metabolism , Cells, Cultured , Genes, Dominant , Humans , Hyperparathyroidism/complications , Hyperparathyroidism/metabolism , Jaw Neoplasms/complications , Jaw Neoplasms/metabolism , Leucine/genetics , Mice , Molecular Sequence Data , Mutant Proteins/genetics , Mutant Proteins/metabolism , Mutant Proteins/physiology , Mutation, Missense/physiology , NIH 3T3 Cells , Pedigree , Phenylalanine/genetics , Protein Transport/genetics , Sequence Homology, Amino Acid , Syndrome , Tumor Suppressor Proteins/physiology
4.
J Neurochem ; 113(5): 1101-12, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20100282

ABSTRACT

The neuronally expressed G beta(5) subunit is the most structurally divergent among heterotrimeric G beta isoforms and unique in its ability to heterodimerize with the R7 subfamily of regulator of G protein signaling (RGS) proteins. The complex between G beta(5) and R7-type RGS proteins targets the cell nucleus by an unknown mechanism. Although the nuclear targeting of the G beta(5)/R7-RGS complex is proposed to involve the binding of R7-binding protein (R7BP), this theory is challenged by the observations that endogenous R7BP is palmitoylated, co-localizes strongly with the plasma membrane, and has never been identified in the cytosol or nucleus of native neurons or untreated cultured cells. We show here mutant RGS7 lacking the N-terminal Disheveled, EGL-10, Pleckstrin homology domain is expressed in transfected cells but, unlike wild-type RGS7, is excluded from the cell nucleus. As the Disheveled, EGL-10, Pleckstrin homology domain is essential for R7BP binding to RGS7, we studied the subcellular localization of G beta(5) in primary neurons and brain from mice deficient in R7BP. The level of endogenous nuclear G beta(5) and RGS7 in neurons and brains from R7BP knockout mice is reduced by 50-70%. These results suggest that R7BP contributes significantly to the nuclear localization of endogenous G beta(5)/R7-RGS complex in brain.


Subject(s)
GTP-Binding Protein beta Subunits/metabolism , Nuclear Localization Signals/physiology , RGS Proteins/metabolism , Animals , Brain Chemistry/physiology , Cell Membrane/metabolism , Cell Nucleus/metabolism , Cell Nucleus/ultrastructure , Cells, Cultured , Cytoplasm/metabolism , Cytoplasm/ultrastructure , DNA, Complementary/biosynthesis , DNA, Complementary/genetics , Fluorescent Antibody Technique , GTP-Binding Protein beta Subunits/genetics , Genotype , Immunoprecipitation , Mice , Mice, Knockout , Microscopy, Confocal , Mutation/physiology , PC12 Cells , RGS Proteins/genetics , Rats , Transfection
5.
J Recept Signal Transduct Res ; 29(6): 326-41, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19899956

ABSTRACT

Ca(2+) release from intracellular stores mediated by endoplasmic reticulum membrane ryanodine receptors (RyR) plays a key role in activating and synchronizing downstream Ca(2+)-dependent mechanisms, in different cells varying from apoptosis to nuclear transcription and development of defensive responses. Recently discovered, atypical "nongenomic" effects mediated by estrogen receptors (ER) include rapid Ca(2+) release upon estrogen exposure in conditions implicitly suggesting involvement of RyRs. In the present study, we report various levels of colocalization between RyR type 2 (RyR2) and ER type beta (ER beta) in the neuronal cell line HT-22, indicating a possible functional interaction. Electrophysiological analyses revealed a significant increase in single-channel ionic currents generated by mouse brain RyRs after application of the soluble monomer of the long form ER beta (ER beta 1). The effect was due to a strong increase in open probability of RyR higher open channel sublevels at cytosolic [Ca(2+)] concentrations of 100 nM, suggesting a synergistic action of ER beta 1 and Ca(2+) in RyR activation, and a potential contribution to Ca(2+)-induced Ca(2+) release rather than to basal intracellular Ca(2+) concentration level at rest. This RyR/ER beta interaction has potential effects on cellular physiology, including roles of shorter ER beta isoforms and modulation of the RyR/ER beta complexes by exogenous estrogens.


Subject(s)
Brain/metabolism , Calcium/metabolism , Estrogen Receptor beta/metabolism , Neurons/metabolism , Ryanodine Receptor Calcium Release Channel/metabolism , Animals , Calcium/agonists , Calcium Signaling/drug effects , Calcium Signaling/physiology , Cell Line , Cytosol/drug effects , Cytosol/metabolism , Humans , Mice , Neurons/drug effects , Protein Isoforms/pharmacology , Recombinant Proteins/pharmacology , Ryanodine Receptor Calcium Release Channel/drug effects
6.
Invest Ophthalmol Vis Sci ; 49(6): 2635-42, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18515593

ABSTRACT

PURPOSE: To determine the extent of retinal ganglion cell loss and morphologic abnormalities in surviving ganglion cells in Ins2 Akita/+ diabetic mice. METHODS: Mice that expressed cyan fluorescent protein (CFP) or yellow fluorescent protein (YFP) reporter genes under the transcriptional control of the Thy1 promoter were crossed with Ins2 Akita/+ mice. After 3 months of diabetes, the number and morphology of retinal ganglion cells was analyzed by confocal microscopy. The number of CFP-positive retinal ganglion cells was quantified in retinas of Ins2(Akita/+) Thy1-CFP mice. The morphology of surviving cells was examined, and dendritic density was quantified in Ins2 Akita/+ Thy1-YFP mice by using the Sholl analysis. RESULTS: Thy1-CFP expression was limited to retinal ganglion cell bodies. There was a 16.4% reduction in the density of CFP-positive ganglion cells in the peripheral retina of Ins2 Akita/+ mice compared with wild-type control retinas (P < 0.017), but no significant change in the central retina. Thy1-YFP expression occurred throughout the entire structure of a smaller number of cells, including their soma, axons, and dendrites. Six different morphologic clusters of cells were identified in the mouse retinas. The structure of dendrites of ON-type retinal ganglion cells was affected by diabetes, having 32.4% more dendritic terminals (P < 0.05), 18.6% increase in total dendrite length (P < 0.05), and 15.3% greater dendritic density compared with control retinas, measured by Scholl analysis. Abnormal swelling on somas, axons, and dendrites were noted in all subtypes of ganglion cells including those expressing melanopsin. CONCLUSIONS: The data show that retinal ganglion cells are lost from the peripheral retina of mice within the first 3 months of diabetes and that the dendrites of surviving large ON-type cells undergo morphologic changes. These abnormalities may explain some of the early anomalies in visual function induced by diabetes.


Subject(s)
Dendrites/pathology , Diabetic Retinopathy/pathology , Disease Models, Animal , Retinal Ganglion Cells/pathology , Animals , Axons/pathology , Blood Glucose/analysis , Diabetes Mellitus, Type 1/genetics , Diabetic Retinopathy/genetics , Female , Fluorescent Antibody Technique, Indirect , Gene Expression/physiology , Genes, Reporter , Green Fluorescent Proteins/genetics , Insulin/genetics , Luminescent Proteins/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Confocal , Retinal Ganglion Cells/metabolism
7.
Curr Eye Res ; 31(7-8): 655-67, 2006.
Article in English | MEDLINE | ID: mdl-16877274

ABSTRACT

Since 1892, anatomical studies have demonstrated that the retinas of mammals, including humans, receive input from the brain via axons emerging from the optic nerve. There are only a small number of these retinopetal axons, but their branches in the inner retina are very extensive. More recently, the neurons in the brain stem that give rise to these axons have been localized, and their neurotransmitters have been identified. One set of retinopetal axons arises from perikarya in the posterior hypothalamus and uses histamine, and the other arises from perikarya in the dorsal raphe and uses serotonin. These serotonergic and histaminergic neurons are not specialized to supply the retina; rather, they are a subset of the neurons that project via collaterals to many other targets in the central nervous system, as well. They are components of the ascending arousal system, firing most rapidly when the animal is awake and active. The contributions of these retinopetal axons to vision may be predicted from the known effects of serotonin and histamine on retinal neurons. There is also evidence suggesting that retinopetal axons play a role in the etiology of retinal diseases.


Subject(s)
Axons/metabolism , Histamine/metabolism , Retina/metabolism , Serotonin/metabolism , Signal Transduction/physiology , Animals , Humans , Optic Nerve/cytology , Optic Nerve/metabolism , Retina/cytology
8.
Invest Ophthalmol Vis Sci ; 47(7): 3143-50, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16799061

ABSTRACT

PURPOSE: To identify amacrine cells that are vulnerable to degeneration during the early stages of diabetes. METHODS: Whole retinas from streptozotocin (STZ)-diabetic rats and Ins2(Akita) mice were fixed in paraformaldehyde. Apoptotic cells in the retina were quantified using terminal dUTP nick-end labeling (TUNEL) and active caspase-3 (CM-1) immunohistochemistry. Immunohistochemical markers for choline acetyltransferase (ChAT) and tyrosine hyroxylase (TH) were also used to quantify populations of amacrine cells in the Ins2Akita mouse retinas. RESULTS: The number of TUNEL-positive nuclei increased from 29+/-4 in controls to 72+/-9 in the STZ-diabetic rat retinas after only 2 weeks of diabetes. In rats, CM-1-immunoreactive (IR) cells were found primarily in the inner nuclear and ganglion cell layers after 2, 8, and 16 weeks of diabetes. At each end point, the number of CM-1-IR cells in the retina was elevated by diabetes. Approximately 2% to 6% of the CM-1-IR cells in the inner nuclear layer (INL) were double-labeled for TH immunoreactivity. After 6 months of diabetes in the Ins2Akita mouse, the morphology of the labeled ChAT-IR and TH-IR amacrine cell somas and dendrites appeared normal. A quantitative analysis revealed a 20% decrease in the number of cholinergic and a 16% decrease in dopaminergic amacrine cells in the diabetic mouse retinas, compared with the nondiabetic control. CONCLUSIONS: Dopaminergic and cholinergic amacrine cells are lost during the early stages of retinal neuropathy in diabetes. Loss of these neurons may play a critical role in the development of visual deficits in diabetes.


Subject(s)
Amacrine Cells/pathology , Apoptosis , Diabetes Mellitus, Experimental/pathology , Diabetic Retinopathy/pathology , Receptors, Cholinergic/metabolism , Receptors, Dopamine/metabolism , Retinal Degeneration/pathology , Amacrine Cells/metabolism , Animals , Caspase 3 , Caspases/metabolism , Cell Count , Choline O-Acetyltransferase/metabolism , Diabetes Mellitus, Experimental/metabolism , Diabetic Retinopathy/metabolism , Fluorescent Antibody Technique, Indirect , In Situ Nick-End Labeling , Male , Mice , Mice, Inbred C57BL , Microscopy, Confocal , Neurons/metabolism , Neurons/pathology , Rats , Rats, Sprague-Dawley , Retinal Degeneration/metabolism , Tyrosine 3-Monooxygenase/metabolism
9.
J Comp Neurol ; 495(6): 658-67, 2006 Apr 20.
Article in English | MEDLINE | ID: mdl-16506196

ABSTRACT

Mammalian retinas are innervated by histaminergic axons that originate from perikarya in the posterior hypothalamus. To identify the targets of these retinopetal axons, we localized histamine receptors (HR) in monkey and rat retinas by light and electron microscopy. In monkeys, puncta containing HR3 were found at the tips of ON-bipolar cell dendrites in cone pedicles and rod spherules, closer to the photoreceptors than the other neurotransmitter receptors. This is the first ultrastructural localization of any histamine receptor and the first direct evidence that HR3 is present on postsynaptic membranes in the central nervous system. In rat retinas, most HR1 were localized to dopaminergic amacrine cells. The differences in histamine receptor localization may reflect the differences in the activity patterns of the two species.


Subject(s)
Histamine/metabolism , Neurons/metabolism , Receptors, Histamine/metabolism , Retina/metabolism , Synapses/metabolism , Amacrine Cells/metabolism , Amacrine Cells/ultrastructure , Animals , Dopamine/metabolism , Efferent Pathways/metabolism , Efferent Pathways/ultrastructure , Immunohistochemistry , Microscopy, Confocal , Microscopy, Electron, Transmission , Neurons/ultrastructure , Papio anubis , Photoreceptor Cells, Vertebrate/metabolism , Photoreceptor Cells, Vertebrate/ultrastructure , Rats , Rats, Sprague-Dawley , Receptors, Histamine H1/metabolism , Receptors, Histamine H3/metabolism , Retina/ultrastructure , Retinal Bipolar Cells/metabolism , Retinal Bipolar Cells/ultrastructure , Species Specificity , Synapses/ultrastructure , Synaptic Membranes/metabolism , Synaptic Membranes/ultrastructure , Synaptic Transmission/physiology
10.
Curr Eye Res ; 30(12): 1089-95, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16354622

ABSTRACT

PURPOSE: To describe serotonergic retinopetal axons in monkeys. METHODS: Whole macaque and baboon retinas, fixed in 4% paraformaldehyde, were labeled with antisera raised against serotonin (5-HT). RESULTS: Several large-diameter 5-HT-immunoreactive (IR) axons emerged from the optic disk. Most axons ran to the peripheral retina, where they branched extensively. Most terminated in the ganglion cell layer, but a few 5-HT-IR axons terminated in distal inner plexiform or within inner nuclear layer. Some axons branched extensively near the fovea, and a dense plexus of 5-HT-IR axons was also found around the optic disk. Varicose 5-HT-IR axons were also associated with blood vessels, especially in the central retina. CONCLUSIONS: Immunoreactive serotonin is present in a distinct population of retinopetal axons in the monkey retina. Receptors for serotonin are present in the primate retinas, and based on physiological studies in other mammals, these retinopetal axons are expected to modulate neuronal activity and regulate blood flow.


Subject(s)
Axons/metabolism , Optic Disk/metabolism , Retina/metabolism , Retinal Ganglion Cells/metabolism , Serotonin/metabolism , Visual Pathways/metabolism , Animals , Female , Macaca mulatta , Nerve Fibers/metabolism , Papio anubis , Receptors, Serotonin/metabolism , Retinal Vessels/metabolism
11.
Vis Neurosci ; 21(6): 935-43, 2004.
Article in English | MEDLINE | ID: mdl-15733348

ABSTRACT

Mammalian retinas receive input from the posterior hypothalamus, and the neurotransmitter in this pathway is histamine. To determine whether histamine influences ganglion cells, we analyzed the effects of histamine on their maintained and light-evoked activity in vitro. In monkeys, histamine increased the maintained firing rate in 42% of ganglion cells, decreased it in 38%, and had no effect in 20%. When histamine and the HR3 agonist, methylhistamine, were applied to the same cells in succession, their effects were sometimes different, a finding suggesting that at least one other histamine receptor is present. In addition, the responses of some ganglion cells to full-field light stimuli were decreased by histamine and methylhistamine. In rats, the effects of histamine were somewhat different. Histamine increased the maintained firing rate of 82% of ganglion cells. Methylhistamine and the HR2 agonist, dimaprit, had the same effects as histamine. In some cells, histamine increased the light responses, but in others it decreased them. Histamine had no effect on ganglion cells in either species when synaptic transmission was blocked by low Ca2(+)/high Mg2+ Ames medium. Thus, the major effects of histamine were on the maintained activity of retinal ganglion cells. In both rats and monkeys, 80% or more of the ganglion cells were affected by histamine, and these responses were mediated by at least two of the histamine receptor subtypes.


Subject(s)
Histamine/pharmacology , Retinal Ganglion Cells/drug effects , Retinal Ganglion Cells/physiology , Action Potentials/drug effects , Action Potentials/radiation effects , Animals , Dimaprit/pharmacology , Electrophysiology , Female , Histamine Agonists/pharmacology , In Vitro Techniques , Light , Macaca mulatta , Methylhistamines/pharmacology , Papio , Rats , Rats, Sprague-Dawley , Retinal Ganglion Cells/radiation effects
SELECTION OF CITATIONS
SEARCH DETAIL
...